16-30985737-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_025193.4(HSD3B7):c.79C>T(p.Arg27*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000392 in 1,607,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_025193.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000253 AC: 6AN: 237074Hom.: 0 AF XY: 0.0000388 AC XY: 5AN XY: 128826
GnomAD4 exome AF: 0.0000405 AC: 59AN: 1455694Hom.: 0 Cov.: 33 AF XY: 0.0000414 AC XY: 30AN XY: 723832
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
HSD3B7-related disorder Pathogenic:1
The HSD3B7 c.79C>T variant is predicted to result in premature protein termination (p.Arg27*). This variant was reported in the homozygous state in an individual with intrahepatic cholestasis (Supp. Table 1, Gorukmez et al. 2023. PubMed ID: 36964972). This variant is reported in 0.0068% of alleles in individuals of South Asian descent in gnomAD. Nonsense variants in HSD3B7 are expected to be pathogenic. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg27*) in the HSD3B7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HSD3B7 are known to be pathogenic (PMID: 12679481). This variant is present in population databases (rs139399987, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with cholestasis (PMID: 36964972). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at